Home › meeting
 

Keywords :   


Tag: meeting

Merck to Present New Data on Investigational Chronic Hepatitis C Treatment Elbasvir/Grazoprevir at The Liver Meeting 2015, Including Phase 3 Results in Selected Difficult-to-Treat Populations

2015-10-20 16:35:00| Merck.com - Research & Development News

Dateline City: KENILWORTH, N.J. New Data Will Also be Presented from Phase 2a C-CREST Trials of Mercks Investigational Triple-Combination Chronic Hepatitis C Therapies KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new data from clinical trials of its investigational treatment portfolio for chronic hepatitis C virus (HCV) are scheduled to be presented at The Liver Meeting 2015 (the 66th annual scientific congress of the American Association for the Study of Liver Diseases) in San Francisco, from Nov. 13-17, 2015. Mercks late-stage investigational portfolio includes elbasvir/grazoprevir1, MK-36822 and MK-84083. Language: English Contact: MerckMedia:Doris Li, 908-246-5701Sarra Herzog, 908-740-1871orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: results including data present

 

Task Force Minutes - Meeting 4

2015-10-20 01:51:33| PortlandOnline

Minutes for Task Force Meeting October 8, 2015 PDF Document, 230kbCategory: Minutes

Tags: minutes meeting force task

 
 

Meeting Materials

2015-10-19 21:44:31| PortlandOnline

Tags: meeting materials meeting materials materials meeting

 

Meeting Agendas and Minutes

2015-10-19 21:44:04| PortlandOnline

Tags: minutes meeting agendas

 

Meeting Calendar

2015-10-19 21:43:33| PortlandOnline

Tags: calendar meeting

 

Sites : [541] [542] [543] [544] [545] [546] [547] [548] [549] [550] [551] [552] [553] [554] [555] [556] [557] [558] [559] [560] next »